𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recent clinical trials with omapatrilat: New developments

✍ Scribed by Anne Zanchi; Marc Maillard; Michel Burnier

Publisher
Springer
Year
2003
Tongue
English
Weight
353 KB
Volume
5
Category
Article
ISSN
1522-6417

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

New targets for immunosuppression in kid
New targets for immunosuppression in kidney transplantation: Focus on recent clinical trials
✍ David Wojciechowski; Flavio Vincenti πŸ“‚ Article πŸ“… 2011 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract Significant advances have been made in post‐kidney transplantation immunosuppression. The introduction of calcineurin inhibitors (CNIs) has led to a reduction in acute rejection and improved 1‐year outcomes. However, long‐term allograft survival has not improved. This may in part be due

Recent developments on 3-hydroxy-4-pyrid
Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applications: Mono and combined ligand approaches
✍ M. AmΓ©lia Santos πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 751 KB

There has been considerable research effort invested in the discovery and development of chelators for the treatment of serious pathological disorders associated with iron (or aluminium) overload in the past two decades. A series of 3-hydroxy-4-pyridinone (3,4-HP) iron-ligands, in particular bis-(3,